EEG Cloud Clinical Service to proactively objectify diagnoses for Neurodegenerative Pathologies and Disorders Therapy

Talks

EEG from bench to bedside: Conventional electrophysiological biomarkers and applied deep learning in Psychiatry
Sebastian Olbrich

Jan. 16
Oscillatory Brain Activity and the Deployment of Attention
John J. Foxe, PhD

Jan. 16
☕

Jan. 16
Non-Invasive Remote EEG Monitoring at Home in Epilepsy: Insights from the EEG@HOME Study
Dr. Andrea Biondi

Jan. 16
To be announced
Prof. Giorgio di Lorenzo

Jan. 16
Contribution of new methods for combined EEG/MEG source analysis and optimized mc-TES to focal medication-resistant epilepsy
Prof. Dr. Carsten Wolters

Jan. 16
🥗

Jan. 16
Decoding Social Touch: EEG Signals Reveal Interdependent Somatosensory Pathways Relevant to Human Affect
Prof. Dr. Annett Schirmer

Jan. 16
Assessing the impact of analytical choices on EEG results: Insights from the EEGManyPipelines project
Prof. Dr. Claudia Gianelli & Dr. Elena Cesnaite

Jan. 16
☕

Jan. 16

Event ANT Neuromeeting 2025 - Berlin starts on Jan 16, 2025, 9:00:00 AM (Europe/Berlin)

Set Favorite

1/18/25, 11:05 AM - 1/18/25, 11:25 AM (Europe/Berlin) (20 minutes)

EEG Cloud Clinical Service to proactively objectify diagnoses for Neurodegenerative Pathologies and Disorders Therapy

Daniel Morera

CEO at CONECTIVA – The Brain Health Company

MSc, Chief Executive Officer at CONECTIVA – The Brain Health Company., Daniel holds a degree in Economics, a Master of Science in European Community Law, and a Master of Science in International Relations and Diplomacy. He has extensive experience in business creation, market launching and operations’ consolidations, in many sectors: business consulting, digital marketing, neuroscience, and digital health. During the last six years he has been dedicated to the general and operations direction at BRAINVESTIGATIONS, and for the last three years, he has been focused on the spin-off CONECTIVA, an Innovative Digital Health BI owned company, where he is in charge of operations and legal representation.

Millions have Brain Diseases and most of them do not know it. Assessment on neurodegenerative pathologies and disorders today is based late, not easily accessible, and expensive medical techniques and non-objectified diagnoses. CONECTIVA is changing this to provide early therapy. We see the opportunity to help people worldwide with early diagnosis to improve their brain health through appropriate therapy, shifting paradigm to approach Brain Disorders. Starting with a typical EEG, we apply an in-house algorithm and, at low cost, we provide an objective diagnosis in less than 5 minutes (Neurofunctional Report).